Landis John B.
Insider CIK 1477283 · EYPT Director · BASI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-01-05 | 2025-01-07 | 10,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-01-05 | 2025-01-07 | 10,000 | — | $0 | 21,400 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 25,014 | — | $0 | 25,014 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 13,000 | — | $0 | 13,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 26,100 | — | $0 | 26,100 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 3,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 3,000 | — | $0 | 11,400 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 3,000 | — | $0 | 3,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2022-02-09 | 2022-02-11 | 2,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2022-02-09 | 2022-02-11 | 2,500 | — | $0 | 8,400 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 2,500 | — | $0 | 2,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2021-02-28 | 2021-03-02 | 1,900 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2021-02-28 | 2021-03-02 | 1,900 | — | $0 | 5,900 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 33,500 | — | $0 | 33,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-06-25 | 2019-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2019-05-13 | 2019-05-15 | 40,000 | $1.74 | $69.6K | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-10-25 | 2018-10-29 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BASI BIOANALYTICAL SYSTEMS INC | P Buy | 2012-08-17 | 2012-08-20 | 30,000 | $1.26 | $37.8K | 30,000 | SEC↗ |
| BASI BIOANALYTICAL SYSTEMS INC | A Award deriv | 2012-07-05 | 2012-07-09 | 15,000 | — | $0 | 15,000 | SEC↗ |